KKR set to hit the jackpot with JB Chemicals and Pharma

The investment giant is rumoured to be eyeing an exit with a 5x return, having taken the drugmaker from obscurity to a billion-dollar bidding war.

30 August, 202414 min
0
KKR set to hit the jackpot with JB Chemicals and Pharma

You may also like

Internet
Story image

Gaurav Munjal to finally exit Unacademy

In the making for many months now, the final outcome at the edtech startup is an instructive episode for both founders and venture investors on when they must let go.

Internet
Story image

Why won’t VCs or anyone else invest in BigBasket?

Early movers don’t always win and other lessons from India’s constantly evolving startup landscape.

Internet
Story image

Does a for-profit motive hurt education?

A popular argument is that we must be wary of private equity investment in education because these funds operate with a profit motive that results in high fees and poor outcomes. This is selective hypocrisy complicated by a lack of choice.